Cancer Research Uk

This study tests a drug called alectinib, already approved for some lung cancers, in people with rare cancers that have a specific genetic change called ALK. About 30 adults, teens, and children with ALK-positive cancers will receive alectinib to see if it shrinks tumors or stops…

This study tests whether drugs already approved for some cancers can help people with rare cancers or common cancers that have rare genetic changes. It includes adults, teenagers, and children whose cancer has a specific mutation and who have no good standard treatment left. The …